Drugs / IgM rich Immunoglobin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03403530 Comparator | Jan → Jun 2018 | neonatal sepsis | Sir Takhtasinhji General Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IgM rich Immunoglobin | “Drug: IgM rich Immunoglobin” NCT03403530 ↗ |
| Modality | Protein / enzyme biologic | “The use of intravenous IgM enriched immunoglobulins” PMID 25674546 ↗ Dec 2014 |
| Route | Intravenous | “'IgM rich immunoglobulin' intravenous infusion” NCT03403530 ↗ |